The use of injectable orthobiologics for knee osteoarthritis: A European ESSKA‐ORBIT consensus. Part 1—Blood‐derived products (platelet‐rich plasma)

Ähnliche Einträge

• The use of injectable orthobiologics for knee osteoarthritis: A formal ESSKA‐ORBIT consensus. Part 2—Cell‐based therapy
  von: Laura de Girolamo, et al.
  Veröffentlicht: (2025)
• Safety profile comparison of intra‐articular corticosteroids, hyaluronic acid, platelet‐rich plasma, and cell‐based injections for knee osteoarthritis: A systematic review and meta‐analysis by the ESSKA Orthobiologics Initiative
  von: Alessandro Bensa, et al.
  Veröffentlicht: (2025)
• Bridging the gender data‐gap in studies of musculoskeletal research
  von: Giuseppe Filardo, et al.
  Veröffentlicht: (2024)
• PRP or not PRP: Is the debate surrounding platelets‐based blood‐derived products evolving?
  von: Enrico Ragni, et al.
  Veröffentlicht: (2025)
• Narrative review and call to action on reporting and representation in orthobiologics research for knee osteoarthritis
  von: Alexander Sin, et al.
  Veröffentlicht: (2024)